SOTAC PHARMACEUTICALS
Back to Cashflow Statement
|
SOTAC PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹16 Cr | ₹29 Cr | ₹13 Cr | ₹-2.83 Cr | ₹3.38 Cr |
What is the latest Cash Flow from Financing Activities ratio of SOTAC PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹16 Cr |
| Mar2024 | ₹29 Cr |
| Mar2023 | ₹13 Cr |
| Mar2022 | ₹-2.83 Cr |
| Mar2021 | ₹3.38 Cr |
How is Cash Flow from Financing Activities of SOTAC PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹16 Cr | -45.43 | |
| Mar2024 | ₹29 Cr | 124.51 | |
| Mar2023 | ₹13 Cr | Positive | |
| Mar2022 | ₹-2.83 Cr | Negative | |
| Mar2021 | ₹3.38 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹123.2 Cr | -10.6% | -19.9% | -5.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -10.6% |
-19.9% |
-5.7% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses